Latest news

Thumbnail image for Anika hit by trial failure

Anika hit by trial failure

US group Anika Therapeutics has been hit by the failure of its viscosupplement Cingal to hit targets in a Phase III trial comparing its effectiveness to a standard treatment in patients with osteoarthritis of the knee.

21st June 2018

Thumbnail image for AdoRx raises $10m for new cancer therapeutics

AdoRx raises $10m for new cancer therapeutics

UK-based drug discovery AdoRx Therapeutics has raised $10 million to fund its work on identifying new cancer therapeutics, in an investment round financed by Epidarex Capital and CRT Pioneer Fund.

21st June 2018

Thumbnail image for UK announces review of medicinal cannabis

UK announces review of medicinal cannabis

Home secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy.

20th June 2018

Thumbnail image for Amgen’s Blincyto gets full EU approval for rare leukaemia

Amgen’s Blincyto gets full EU approval for rare leukaemia

European regulators have awarded Amgen’s Blincyto full approval for Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the blood and bone marrow thought to affect around 900 patients a year in the region.

20th June 2018

Thumbnail image for US approves joint damage data for Cosentyx

US approves joint damage data for Cosentyx

US regulators have approved new evidence showing that Novartis’ Cosentyx significantly slows progression of joint structural damage in patients with active psoriatic arthritis (PsA).

20th June 2018

Previous  --   2 3 4 5 6 7 8 9 10 11   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download